Literature DB >> 22570371

Targeted deletion of microRNA-22 promotes stress-induced cardiac dilation and contractile dysfunction.

Priyatansh Gurha1, Cei Abreu-Goodger, Tiannan Wang, Maricela O Ramirez, Ana L Drumond, Stijn van Dongen, Yuqing Chen, Nenad Bartonicek, Anton J Enright, Brendan Lee, Robert J Kelm, Anilkumar K Reddy, George E Taffet, Allan Bradley, Xander H Wehrens, Mark L Entman, Antony Rodriguez.   

Abstract

BACKGROUND: Delineating the role of microRNAs (miRNAs) in the posttranscriptional gene regulation offers new insights into how the heart adapts to pathological stress. We developed a knockout of miR-22 in mice and investigated its function in the heart. METHODS AND
RESULTS: Here, we show that miR-22-deficient mice are impaired in inotropic and lusitropic response to acute stress by dobutamine. Furthermore, the absence of miR-22 sensitized mice to cardiac decompensation and left ventricular dilation after long-term stimulation by pressure overload. Calcium transient analysis revealed reduced sarcoplasmic reticulum Ca(2+) load in association with repressed sarcoplasmic reticulum Ca(2+) ATPase activity in mutant myocytes. Genetic ablation of miR-22 also led to a decrease in cardiac expression levels for Serca2a and muscle-restricted genes encoding proteins in the vicinity of the cardiac Z disk/titin cytoskeleton. These phenotypes were attributed in part to inappropriate repression of serum response factor activity in stressed hearts. Global analysis revealed increased expression of the transcriptional/translational repressor purine-rich element binding protein B, a highly conserved miR-22 target implicated in the negative control of muscle expression.
CONCLUSION: These data indicate that miR-22 functions as an integrator of Ca(2+) homeostasis and myofibrillar protein content during stress in the heart and shed light on the mechanisms that enhance propensity toward heart failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570371      PMCID: PMC3503489          DOI: 10.1161/CIRCULATIONAHA.111.044354

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  39 in total

1.  Puralpha and Purbeta collaborate with Sp3 to negatively regulate beta-myosin heavy chain gene expression during skeletal muscle inactivity.

Authors:  Juan Ji; Gretchen L Tsika; Hansjörg Rindt; Kathy L Schreiber; John J McCarthy; Robert J Kelm; Richard Tsika
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

2.  Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.

Authors:  Xu-Dong Xu; Xiao-Wei Song; Qing Li; Guo-Kun Wang; Qing Jing; Yong-Wen Qin
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

3.  TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity.

Authors:  Richard Tomasini; Mylène Seux; Jonathan Nowak; Caroline Bontemps; Alice Carrier; Jean-Charles Dagorn; Marie-Josèphe Pébusque; Juan L Iovanna; Nelson J Dusetti
Journal:  Oncogene       Date:  2005-12-08       Impact factor: 9.867

4.  Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors:  Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal:  Science       Date:  2007-03-22       Impact factor: 47.728

Review 5.  Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets.

Authors:  Abhinav Diwan; Gerald W Dorn
Journal:  Physiology (Bethesda)       Date:  2007-02

Review 6.  Serum response factor micromanaging cardiogenesis.

Authors:  Zhivy Niu; Ankang Li; Shu X Zhang; Robert J Schwartz
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

Review 7.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

8.  The single-strand DNA/RNA-binding protein, Purbeta, regulates serum response factor (SRF)-mediated cardiac muscle gene expression.

Authors:  Madhu Gupta; Vithida Sueblinvong; Mahesh P Gupta
Journal:  Can J Physiol Pharmacol       Date:  2007 Mar-Apr       Impact factor: 2.273

9.  Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure.

Authors:  Hiroyuki Nakayama; Xiongwen Chen; Christopher P Baines; Raisa Klevitsky; Xiaoying Zhang; Hongyu Zhang; Naser Jaleel; Balvin H L Chua; Timothy E Hewett; Jeffrey Robbins; Steven R Houser; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 10.  Sarcomeric proteins and inherited cardiomyopathies.

Authors:  Sachio Morimoto
Journal:  Cardiovasc Res       Date:  2007-12-04       Impact factor: 10.787

View more
  76 in total

1.  Purine-rich element binding protein B attenuates the coactivator function of myocardin by a novel molecular mechanism of smooth muscle gene repression.

Authors:  Lauren A Ferris; Andrea T Foote; Shu-Xia Wang; Robert J Kelm
Journal:  Mol Cell Biochem       Date:  2021-03-20       Impact factor: 3.396

2.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.

Authors:  Neveen Abd El Moneim Hussein; Zenat A El Kholy; Medhat M Anwar; Mohamed A Ahmad; Shaymaa M Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-15       Impact factor: 4.553

3.  HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility.

Authors:  Allison Lesher Williams; Chad B Walton; Keith A MacCannell; Abigail Avelar; Ralph V Shohet
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-12-21       Impact factor: 4.733

4.  How to be young at heart? miR-22 as a potential therapeutic target to boost autophagy and protect the old myocardium.

Authors:  Sebastiano Sciarretta; Elena De Falco; Giacomo Frati; Junichi Sadoshima
Journal:  Ann Transl Med       Date:  2017-02

5.  Global analyses of the effect of different cellular contexts on microRNA targeting.

Authors:  Jin-Wu Nam; Olivia S Rissland; David Koppstein; Cei Abreu-Goodger; Calvin H Jan; Vikram Agarwal; Muhammed A Yildirim; Antony Rodriguez; David P Bartel
Journal:  Mol Cell       Date:  2014-03-13       Impact factor: 17.970

6.  Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.

Authors:  C Koufaris; G N Valbuena; Y Pomyen; G D Tredwell; E Nevedomskaya; C-He Lau; T Yang; A Benito; J K Ellis; H C Keun
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

Review 7.  The biological functions of miRNAs: lessons from in vivo studies.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Trends Cell Biol       Date:  2014-12-04       Impact factor: 20.808

8.  More than just an engine: the heart regulates body weight.

Authors:  Heinrich Taegtmeyer; Antony Rodriguez
Journal:  Circ Res       Date:  2012-08-17       Impact factor: 17.367

9.  MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress.

Authors:  Zhan-Peng Huang; Jinghai Chen; Hee Young Seok; Zheng Zhang; Masaharu Kataoka; Xiaoyun Hu; Da-Zhi Wang
Journal:  Circ Res       Date:  2013-03-22       Impact factor: 17.367

Review 10.  MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle.

Authors:  Ahmed Omran; Dalia Elimam; Keith A Webster; Lina A Shehadeh; Fei Yin
Journal:  Cardiol Young       Date:  2013-02-26       Impact factor: 1.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.